Peter Lynch
Impact in
-
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Treatment and Management
- Diabetes Management and Education
-
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
Papers in
-
- Diabetes Management and Research 19
- Diabetes Treatment and Management 5
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 1
- Genetics 7
- Diabetes and associated disorders 7
- Co-authors
- Stéphane Roze (10 shared papers)John J. Isitt (7 shared papers)Gregory J. Norman (6 shared papers)Daniel Flanagan (1 shared paper)D. Wright (1 shared paper)Jayne Smith‐Palmer (4 shared papers)Eileen M. Moore (1 shared paper)Claudia Graham (2 shared papers)
- Journals
- Value in Health (4 papers)Diabetic Medicine (2 papers)Diabetes Therapy (2 papers)Diabetes (2 papers)Heliyon (2 papers)
- Partner nations
- United StatesIrelandUnited Kingdom
In The Last Decade
Peter Lynch
30 papers receiving 388 citations
Peers
Comparison fields: 5 of 62
- Endocrinology, Diabetes and Metabolism 243
- Neurology 42
- Genetics 58
- Surgery 73
- Geriatrics and Gerontology 4
Countries citing papers authored by Peter Lynch
This map shows the geographic impact of Peter Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lynch more than expected).
Fields of papers citing papers by Peter Lynch
This network shows the impact of papers produced by Peter Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lynch. The network helps show where Peter Lynch may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Lynch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 63 | |
| 2 | 2018 | 44 | |
| 3 | 2008 | 38 | |
| 4 | 2020 | 34 | |
| 5 | 2022 | 31 | |
| 6 | 2022 | 25 | |
| 7 | 2020 | 18 | |
| 8 | Resource utilization with insulin pump therapy for type 2 diabetes mellitus. | 2010 | 17 |
| 9 | 2022 | 13 | |
| 10 | 2021 | 13 | |
| 11 | 2023 | 12 | |
| 12 | 2023 | 12 | |
| 13 | 2016 | 11 | |
| 14 | 2010 | 10 | |
| 15 | 2016 | 10 | |
| 16 | 2024 | 9 | |
| 17 | 2023 | 9 | |
| 18 | 2021 | 8 | |
| 19 | 2019 | 7 | |
| 20 | 2021 | 6 |
About Peter Lynch
Peter Lynch is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Neurology and Rehabilitation, having authored 32 papers that have together received 409 indexed citations. Recurring topics across this work include Diabetes Management and Research (19 papers), Diabetes and associated disorders (7 papers), Diabetes Treatment and Management (5 papers), Pancreatic function and diabetes (4 papers), Stroke Rehabilitation and Recovery (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Retinal Diseases and Treatments (1 paper) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (243 citations), Neurology (42 citations), Genetics (58 citations), Surgery (73 citations) and Geriatrics and Gerontology (4 citations). Peter Lynch has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Stéphane Roze, John J. Isitt, Gregory J. Norman, Daniel Flanagan, D. Wright, Jayne Smith‐Palmer, Eileen M. Moore, Claudia Graham, Michael E. Minshall and Fatta B. Nahab. Their work appears in journals such as Value in Health, Diabetic Medicine, Diabetes Therapy, Diabetes and Heliyon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.